NCT05955846View on ClinicalTrials.gov

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Intraocular LensCataractPresbyopia
Interventions
PROCEDURE

cataract surgery

Subjects will undergo surgery to remove cataract (natural cloudy lens) via phacoemulsification implant the IOL Both eyes will be treated one month apart. Subjects will be followed up during 12 months

DEVICE

implantation of device IOL FG-80030.1

implant the IOL in both eyes. Both eyes will be treated one month apart. Subjects will be followed up during 12 months

All Listed Sponsors
lead

Z Optics, Inc.

INDUSTRY

NCT05955846 - Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic | Biotech Hunter | Biotech Hunter